However, the adverse effects, especially the adverse CV effect between them remain unclear.<h4>Methods</h4>Through a literature search using MEDLINE, EMBASE and the Cochrane Library, all available studies comparing the safety of CV risk between GnRH antagonists and GnRH agonists in Pca patients were extracted. The gene discussed is GNRH1; the disease is posterior cortical atrophy.